Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« In the Pipeline: A Drug Development Blog | Main | Evolution IS a Fact »

April 7, 2003

Fishing Depression Away

Email This Entry

Posted by Zack Lynch

You are what you eat, or perhaps more accurately, you feel what you eat.  Research continues to show that at a specific nutrient contained in fish can help alleviate depression. The nutrient is an omega-3 fatty acid called EPA.


Healthy brains and nerve cells depend on omega-3s because the nervous system is made mostly of fat.  The fats that you eat influence the composition of your brain cells. Unlike many nutrients omega-3 fatty acids are not produced by our bodies.  Fish are an excellent source.


And if you don't like fish, you can also get your fill from walnuts or flaxseed.

Comments (0) | Category: Mental Health Issues



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives